Frailty, sarcopenia and diabetic kidney disease: where do we stand?

被引:0
作者
Nikolaos D. Karakousis
Smaragda Biliou
Elisavet E. Pyrgioti
Petros N. Georgakopoulos
Vassilios Liakopoulos
Nikolaos Papanas
机构
[1] Primary Healthcare,Division of Nephrology and Hypertension, First Department of Internal Medicine
[2] Internal Medicine Department,Diabetes Centre
[3] Internist,Diabetic Foot Clinic
[4] Private Practice,undefined
[5] Pharmacist,undefined
[6] Private Practice,undefined
[7] AHEPA Hospital,undefined
[8] Aristotle University of Thessaloniki,undefined
[9] Second Department of Internal Medicine,undefined
[10] Democritus University of Thrace,undefined
来源
International Urology and Nephrology | 2023年 / 55卷
关键词
Frailty; Sarcopenia; Diabetes mellitus; Type 2 diabetes mellitus; Diabetic kidney disease; Diabetic renal disease;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this narrative non-systematic review was to investigate the potential interplay among frailty syndrome, sarcopenia and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) patients. Data derived from a limited number of studies underline that DKD is a significant risk factor for frailty. On the other hand, frailty syndrome poses a higher risk for end-stage renal disease (ESRD) in subjects with DKD. In addition, frailty seems to affect the cognitive function and social life of DKD individuals, whilst as DKD deteriorates, there is a higher prevalence of sarcopenia which is a fundamental frailty factor. As a result, it is shown that a bidirectional relation is established between these entities, as diabetes mellitus (DM) affects the components of frailty and sarcopenia and vice versa. This vicious cycle is created through multiple pathophysiologic mechanisms, including the anabolic role of insulin, low-grade inflammation, cytokines and endothelial function, prompting further investigation in this area. Specific nutritional and exercise interventions are imperative to be established in order to ameliorate potential adverse outcomes, concerning these entities.
引用
收藏
页码:1173 / 1181
页数:8
相关论文
共 257 条
[11]  
Cruz-Jentoft AJ(1996)Patterns of renal injury in NIDDM patients with microalbuminuria Diabetologia 39 1569-1576
[12]  
Bahat G(2018)Update of pathophysiology and management of diabetic kidney disease J Formos Med Assoc 117 662-675
[13]  
Bauer J(2020)Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy Int J Mol Sci 21 3798-96
[14]  
Boirie Y(2020)Genetics of frailty: a longevity perspective Transl Res 221 83-38
[15]  
Bruyere O(2018)Frailty screening and interventions: considerations for clinical practice Clin Geriatr Med 34 25-1386
[16]  
Cederholm T(2019)Management of frailty: opportunities, challenges, and future directions Lancet 394 1376-49
[17]  
Woo J(2019)Sarcopenia, frailty and their prevention by exercise Free Radic Biol Med 132 42-61
[18]  
Alicic RZ(2020)Frailty assessment and postoperative complications in urologic oncology operations J Frailty Sarcopenia Falls 5 57-26
[19]  
Rooney MT(2020)A multidimensional approach to frailty in older people Ageing Res Rev 60 101047-17
[20]  
Tuttle KR(2021)Are diabetes-related factors associated with the social roles of elderly patients with diabetes? J Diabetes Complicat 35 17-466